Catalyst Metals Limited

CYL

Catalyst Metals Ltd. engages in the acquisition, exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-07-26. The firm owns the 40 kilometers (km) long Plutonic Gold Belt in Western Australia hosting the Plutonic gold mine and neighboring underexplored, high-grade resources. The Plutonic Gold Mine is located over 300 km northeast of Meekatharra in the mid-west region of Western Australia, at the northern end of the Eastern Gold Fields Province. The company also owns and operates the high-grade Henty Gold Mine in Tasmania, which lies within the 25 km Henty gold belt. The company also controls +75 km of strike length immediately north of the +22Moz Bendigo goldfield and home to high-grade, greenfield resources at Four Eagles. The company has interests in over 13 exploration licenses and two retention licenses along the Whitelaw and Tandarra Faults north of Bendigo and in other areas north of the Fosterville and Inglewood gold fields. Four Eagles Gold Project is situated along the Whitelaw Gold Corridor.

Cyprium Metals Limited

CYM

Cyprium Metals Ltd. engages in the exploration of gold and copper deposits in Indonesia. The company is headquartered in Subiaco, Western Australia. The Company’s flagship property is the Nifty Copper Mine in Western Australia, which produces copper from both oxide and sulfide resources. The Nifty Copper Mine is located on the western edge of the Great Sandy Desert in the north-eastern Pilbara region of Western Australia, approximately 350 kilometers (km) southeast of Port Hedland. Its other assets include copper-focused properties in the Paterson and Murchison Provinces, including multiple defined resources. Its Maroochydore deposit is located in the north-eastern Pilbara region of Western Australia, approximately 85km southeast of Nifty. Paterson Exploration Project is located in the north-eastern Pilbara region of Western Australia and covers over 2,400 km2 land package. The Murchison Copper Gold Project, comprising the Cue and Nanadie Well Copper Projects, is in the eastern Murchison region of Western Australia, over 20km east of Cue and 75km southeast of Meekatharra.

Cygnus Metals Limited

CY5

Cygnus Metals Ltd. engages in the exploration and discovery of gold deposits in the Southwest Terrane of the Yilgarn Crato, Western Australia. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-01-15. The firm is focused on advancing the Pontax Lithium Project (earning up to 70%), the Auclair Lithium Project and Sakami Lithium Project in the James Bay lithium district in Canada. In addition, the Company has rare earth elements (REE) and base metal projects at Bencubbin and Snake Rock in Western Australia. The Pontax Lithium Project is situated within the lithium province of James Bay in Northern Quebec, Canada. The Pontax Project covers approximately 183 kilometers (km2) landholding all located on category III lands. The Auclair Project covers over 417 km2 landholding located just 60 km north-east of the Whabouchi lithium mine. The Sakami Project is a landholding of 118 km2 covering the highly prospective La Grande greenstone belt. The company has approximately 1,750 km2 of granted tenements located over underexplored greenstone belts prospective for lithium, REEs, nickel, copper, platinum group elements (PGEs) and gold.

Cyclopharm Limited

CYC

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in diagnostic imaging in lung health. The firm's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The firm uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The firm distributes its products in approximately 65 countries.